Our expertise in discovering, developing and commercializing innovative medical imaging agents provides a strong platform to bring forward breakthrough tools for the diagnosis and management of disease. Lantheus provides a broad portfolio of products, which are primarily used for the diagnosis of cardiovascular diseases.Ĭlinicians use our imaging agents and products across a range of imaging modalities, including nuclear imaging, echocardiography and magnetic resonance imaging (MRI). Lantheus Medical Imaging is a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents. Uranium (LEU) targets, making Lantheus the first company to use Mo-99 sourced from LEU Lantheus announced the distribution of TechneLite ® generators using Mo-99 produced with low-enriched Use highly enriched uranium (HEU) targets, which pose a global security threat. All of the supply is imported into the United States from nuclear reactors that primarily There are a number of worldwide suppliers of The company has secured numerous partnerships and agreements with suppliers and partners worldwide to maximize access to Supply Mo-99, Lantheus has aggressively undertaken several key initiatives to implement a diversifiedĪnd balanced supply chain of Mo-99 for its TechneLite ® generators. In order to ensure the consistency and reliability that are the hallmarks of the TechneLite ® brand, the generators are calibrated on-site on the same day of manufacturing every Monday,Īs a result of aging and increasingly less reliable nuclear reactors that Lantheus is committed to ensuring that the medical imaging community has reliableĪnd secure access to TechneLite ® (Technetium Tc-99m Generator) to meet the healthcare needs of patients.

Lantheus Medical Imaging - committed to meeting the needs of the nuclear medicine community

Technetium 99-m generator